JAMONY
FBIO icon

Jacob Asset Management of New York’s Fortress Biotech FBIO Stock Holding History

Jacob Asset Management of New York’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$536K Buy
5,093
+1,760
+53% +$216K 0.66% 51
2013
Q2 		$430K Buy
+3,333
New +$491K 0.58% 53

Other funds holding FBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Jacob Asset Management of New York's FBIO Position: Q3 2013 in Review

Jacob Asset Management of New York increased its Fortress Biotech (FBIO) stake by 53% in Q3 2013, buying an estimated $216K and bringing the position to 5,093 shares worth $536K. The position accounts for 0.66% of the portfolio, ranked #51.

Jacob Asset Management of New York first reported a position in FBIO in Q2 2013 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold FBIO as of Q3 2013.

  • Jacob Asset Management of New York held 5,093 shares of Fortress Biotech worth $536K as of Q3 2013.
  • Jacob Asset Management of New York bought 1,760 Fortress Biotech shares in Q3 2013, an estimated $216K.
  • Fortress Biotech made up 0.66% of Jacob Asset Management of New York's portfolio in Q3 2013, its #51 holding.
  • Jacob Asset Management of New York first reported a position in Fortress Biotech in Q2 2013 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2013.

Based on Jacob Asset Management of New York's 13F filing for Q3 2013, filed 14 Nov 2013.